We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$18.4B
AUM Growth
-$1.1B
Cap. Flow
-$780M
Cap. Flow %
-4.25%
Top 10 Hldgs %
40.19%
Holding
562
New
65
Increased
161
Reduced
196
Closed
78

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$162M
2
INCY icon
Incyte
INCY
+$120M
3
DHR icon
Danaher
DHR
+$112M
4
ADSK icon
Autodesk
ADSK
+$95M
5
BAC icon
Bank of America
BAC
+$92.8M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$245M
2
AAPL icon
Apple
AAPL
+$178M
3
ASML icon
ASML
ASML
+$125M
4
MO icon
Altria Group
MO
+$119M
5
AGN
Allergan plc
AGN
+$118M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Communication Services 18.39%
3 Healthcare 16.44%
4 Consumer Discretionary 11.83%
5 Industrials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
501
Heron Therapeutics
HRTX
$86.3M
-81,903
Closed -$1.41M
IMOS
502
ChipMOS TECHNOLOGIES
IMOS
$1.92B
-17,307
Closed -$378K
JAZZ icon
503
Jazz Pharmaceuticals
JAZZ
$15.9B
-21
Closed -$3K
JD icon
504
JD.com
JD
$40.8B
-20,606
Closed -$538K
LEA icon
505
Lear
LEA
$7.19B
-153,504
Closed -$18.6M
MCO icon
506
Moody's
MCO
$81.7B
-9,478
Closed -$1.03M
NCLH icon
507
Norwegian Cruise Line
NCLH
$8.89B
-2,363,032
Closed -$89.1M
NGVT icon
508
Ingevity
NGVT
$2.55B
-58
Closed -$3K
NVO
509
Novo Nordisk
NVO
$216B
-34,000
Closed -$707K
PACB icon
510
Pacific Biosciences
PACB
$422M
-10,000
Closed -$90K
PENN icon
511
PENN Entertainment
PENN
$2.74B
-187
Closed -$3K
PGR icon
512
Progressive
PGR
$124B
-174
Closed -$5K
PSX icon
513
Phillips 66
PSX
$82.9B
-56
Closed -$5K
PTEN icon
514
Patterson-UTI
PTEN
$3.87B
-48,373
Closed -$1.08M
RDHL
515
Redhill Biopharma
RDHL
$3.85M
-22
Closed -$299K
RGNX icon
516
Regenxbio
RGNX
$623M
-14,000
Closed -$196K
SGRY icon
517
Surgery Partners
SGRY
$2.06B
-162,864
Closed -$3.3M
SIG icon
518
Signet Jewelers
SIG
$3.55B
-526,074
Closed -$39.2M
SITE icon
519
SiteOne Landscape Supply
SITE
$4.43B
-25,596
Closed -$920K
STE icon
520
Steris
STE
$20.9B
-1,120,557
Closed -$81.9M
TBPH icon
521
Theravance Biopharma
TBPH
$874M
-19,000
Closed -$689K
TEVA icon
522
Teva Pharmaceuticals
TEVA
$35.9B
-25,970
Closed -$1.2M
TGTX icon
523
TG Therapeutics
TGTX
$8.58B
-70,000
Closed -$542K
THS
524
DELISTED
Treehouse Foods
THS
-81,486
Closed -$7.11M
TNDM icon
525
Tandem Diabetes Care
TNDM
$1.17B
-2,000
Closed -$153K

Similar funds

Fred Alger Management's Q4 2016 Portfolio in Review

As of Q4 2016, Fred Alger Management held 562 positions worth $18.4B, down 5.7% from $19.5B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fred Alger Management withdrew a net $780M in Q4 2016, closing 78 positions and reducing 196 holdings. Its most notable exit was Norwegian Cruise Line, an estimated $89.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Fred Alger Management opened a new position in Autodesk worth $95.4M.

  • Fred Alger Management's largest Q4 2016 buy was Autodesk: 1,289,679 shares worth $95.4M.
  • Fred Alger Management added most to Intercontinental Exchange in Q4 2016, an estimated $162M increase.
  • Fred Alger Management's biggest Q4 2016 reduction was Thermo Fisher Scientific, cutting an estimated $245M.
  • Fred Alger Management fully exited Norwegian Cruise Line in Q4 2016, selling an estimated $89.1M.
  • Fred Alger Management's ten largest holdings make up 40% of its $18.4B portfolio in Q4 2016.
  • Fred Alger Management opened 65 new positions and closed 78 in Q4 2016.
  • Fred Alger Management's portfolio value fell 5.7% quarter-over-quarter to $18.4B.

Based on Fred Alger Management's 13F filing for Q4 2016, filed 14 Feb 2017.